EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunonutrition vs standard nutrition for patients with cancer

Sandra Kavalukas, Stephen A McClave

Nutrition in Clinical Practice · 2023-08 · 38 (4) · 924-931

DOI: 10.1002/ncp.10963 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrition in Clinical Practice, online erschienen am 14.02.2023. Verfasst von Sandra Kavalukas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Louisville School of Medicine, Louisville, Kentucky, USA. Hauptthemen laut MEDLINE: Neoplasms, Nutritional Status. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevailing belief in the value of immunonnutrition has been questioned as different patient populations show variable responses ranging from no benefit or even harm to significant improvements in clinical outcomes. The subject of this invited review is a previously published meta‐analysis that showed important benefits from the perioperative use of an immunonutrition formula (defined as nutrition therapy that contains specific immune‐modulating agents) in a distinct population: adult patients with cancer undergoing an elective major surgical operation. Findings showed that use of an immunonutrition formula was associated with reduced infectious morbidity, anastomotic leakage, hospital length of stay, and postoperative complications compared with standard formulations. These benefits were seen after adjusting for bias and removal of older publications. Issues, such as dosing, duration of therapy, baseline nutrition status, content of specific immunomodulatory agents, and route of delivery that contributed to the beneficial response, were discussed. Little difference in response was seen between well‐nourished and malnourished patients, but geographic differences were seen, with greater outcome benefits seen in studies originating from Europe than from Asia or the United States. The best results were seen when at least three agents (arginine, fish oil, and RNA nucleotides) were given, with the timing of the delivery occurring throughout the perioperative period. A review of this meta‐analysis is warranted because it shows a consistent benefit from such therapy over 30 years of clinical research, provides a detailed subset analysis of related issues, and highlights its value in improving outcome in this patient population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNutritional StatusHumansEnteral NutritionImmunonutrition DietLength of StayNutritional SupportPostoperative Complications

Stichwörter der Autor:innen

argininecancerenteral nutritionglutamineimmunonutritionnutrition supportoutcomes

Autor:innen und Institutionen

  • Department of Surgery, University of Louisville School of Medicine, Louisville, Kentucky, USA.
  • Department of Medicine, University of Louisville School of Medicine, Louisville, Kentucky, USA.

Zitieren

APA

Kavalukas, S., & McClave, S. A. (2023). Immunonutrition vs standard nutrition for patients with cancer. Nutrition in Clinical Practice, 38(4), 924-931. https://doi.org/10.1002/ncp.10963

Vancouver

Kavalukas S, McClave SA. Immunonutrition vs standard nutrition for patients with cancer. Nutrition in Clinical Practice. 2023;38(4):924-931. doi:10.1002/ncp.10963

BibTeX
@article{Kavalukas2023,
  author = {Kavalukas, Sandra and McClave, Stephen A},
  title = {Immunonutrition vs standard nutrition for patients with cancer},
  journal = {Nutrition in Clinical Practice},
  year = {2023},
  volume = {38},
  number = {4},
  pages = {924--931},
  doi = {10.1002/ncp.10963}
}
Kostenlos starten →